Published in Women's Health Weekly, June 19th, 2003
The lowest dose of Paxil CR, 12.5 mg per day, was shown to reduce overall symptoms and was well-tolerated with a low rate of patient drop outs. Similar results were seen with 25mg per day dose. Paxil CR is currently under review by the U.S. Food and Drug Administration as a treatment for PMDD.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly